Endurant Capital Management LP Buys Humana Inc, Johnson & Johnson, AbbVie Inc, Sells Thermo Fisher Scientific Inc, Laboratory Corp of America Holdings, Cigna Corp

• New Purchases: MCK, ATR, AHCO, PKI, BDX, SNY, AXSM, MRVI, KRYS, BOLT, BOLT, ALVR, XENE, PDCO,
• Added Positions: HUM, JNJ, ABBV, SIBN, HOLX, BMY, BIO, OMI, VCYT, RGLS, AZYO, ALBO, OCUL, SELB, AVTR, IMUX,
• Reduced Positions: LH, CI, ICLR, RCM, PHAS, SYNH, INSM, XRAY, ADAP, THC, ABC, DRIO, IVC, MTEM, ACRS, PRAX, IOVA, BLU, CYAD, MREO,
• Sold Out: TMO, HAE, EAR, TRIL, ANTM, FATE, SBTX, CALT, MDVL, REGN, TFX, SRPT, BAX, PNTG, FBRX, VRTX, CANO, PRVB, XFOR,

For the details of Endurant Capital Management LP's stock buys and sells, go to https://www.gurufocus.com/guru/endurant+capital+management+lp/current-portfolio/portfolio

1. S&P 500 ETF TRUST ETF (SPY) - 25,300 shares, 19.34% of the total portfolio.
2. Trillium Therapeutics Inc (TRIL) - 206,800 shares, 9.51% of the total portfolio.
3. AbbVie Inc (ABBV) - 180,429 shares, 5.10% of the total portfolio. Shares added by 110.99%
4. Humana Inc (HUM) - 44,022 shares, 4.49% of the total portfolio. Shares added by 178.78%
5. Johnson & Johnson (JNJ) - 98,077 shares, 4.15% of the total portfolio. Shares added by 197.22%

Endurant Capital Management LP initiated holding in McKesson Corp. The purchase prices were between $188.42 and $208.66, with an estimated average price of $199.89. The stock is now traded at around $221.550000. The impact to a portfolio due to this purchase was 1.7%. The holding were 32,551 shares as of 2021-09-30.

Endurant Capital Management LP initiated holding in AptarGroup Inc. The purchase prices were between $119.35 and $141.18, with an estimated average price of $131.75. The stock is now traded at around $134.840000. The impact to a portfolio due to this purchase was 1.6%. The holding were 51,191 shares as of 2021-09-30.

Endurant Capital Management LP initiated holding in AdaptHealth Corp. The purchase prices were between $21.49 and $27.46, with an estimated average price of $24.23. The stock is now traded at around $25.300000. The impact to a portfolio due to this purchase was 1.19%. The holding were 194,886 shares as of 2021-09-30.

Endurant Capital Management LP initiated holding in PerkinElmer Inc. The purchase prices were between $151.98 and $190.5, with an estimated average price of $176.11. The stock is now traded at around $186.460000. The impact to a portfolio due to this purchase was 0.87%. The holding were 19,264 shares as of 2021-09-30.

Endurant Capital Management LP initiated holding in Becton, Dickinson and Co. The purchase prices were between $238.54 and $262.88, with an estimated average price of $251.45. The stock is now traded at around $245.100000. The impact to a portfolio due to this purchase was 0.71%. The holding were 11,077 shares as of 2021-09-30.

Endurant Capital Management LP initiated holding in Sanofi SA. The purchase prices were between $47.89 and $53.12, with an estimated average price of $50.89. The stock is now traded at around $51.030000. The impact to a portfolio due to this purchase was 0.69%. The holding were 54,821 shares as of 2021-09-30.

Endurant Capital Management LP added to a holding in Humana Inc by 178.78%. The purchase prices were between $389.15 and $471.22, with an estimated average price of $424.73. The stock is now traded at around $450.150000. The impact to a portfolio due to this purchase was 2.88%. The holding were 44,022 shares as of 2021-09-30.

Endurant Capital Management LP added to a holding in Johnson & Johnson by 197.22%. The purchase prices were between $161.5 and $179.47, with an estimated average price of $170.65. The stock is now traded at around $162.910000. The impact to a portfolio due to this purchase was 2.75%. The holding were 98,077 shares as of 2021-09-30.

Endurant Capital Management LP added to a holding in AbbVie Inc by 110.99%. The purchase prices were between $106.4 and $120.78, with an estimated average price of $114.24. The stock is now traded at around $116.950000. The impact to a portfolio due to this purchase was 2.68%. The holding were 180,429 shares as of 2021-09-30.

Endurant Capital Management LP added to a holding in SI-BONE Inc by 1073.49%. The purchase prices were between $19.65 and $31.89, with an estimated average price of $25.38. The stock is now traded at around $21.825000. The impact to a portfolio due to this purchase was 2.42%. The holding were 471,214 shares as of 2021-09-30.

Endurant Capital Management LP added to a holding in Hologic Inc by 80.55%. The purchase prices were between $67.56 and $80.74, with an estimated average price of $74.96. The stock is now traded at around $73.250000. The impact to a portfolio due to this purchase was 1.73%. The holding were 200,119 shares as of 2021-09-30.

Endurant Capital Management LP added to a holding in Bristol-Myers Squibb Co by 109.56%. The purchase prices were between $59.17 and $69.31, with an estimated average price of $65.87. The stock is now traded at around $59.365000. The impact to a portfolio due to this purchase was 1.71%. The holding were 211,821 shares as of 2021-09-30.

Endurant Capital Management LP sold out a holding in Thermo Fisher Scientific Inc. The sale prices were between $509.53 and $609.78, with an estimated average price of $548.6.

Endurant Capital Management LP sold out a holding in Haemonetics Corp. The sale prices were between $57.6 and $70.59, with an estimated average price of $63.18.

Endurant Capital Management LP sold out a holding in Eargo Inc. The sale prices were between $6.59 and $38.71, with an estimated average price of $26.78.

Endurant Capital Management LP sold out a holding in Trillium Therapeutics Inc. The sale prices were between $5.86 and $17.8, with an estimated average price of $11.74.

Endurant Capital Management LP sold out a holding in Anthem Inc. The sale prices were between $357.51 and $398.13, with an estimated average price of $380.13.

Endurant Capital Management LP sold out a holding in Fate Therapeutics Inc. The sale prices were between $59.27 and $95.73, with an estimated average price of $78.58.